We provide unique Work Loop models for the assessment of inotropy in human cardiac muscles and primary myocytes.
Coventry
Joined June 2020
- Tweets10
- Following41
- Followers21
- Likes2
Snapshot from our presentation at @SafetyPharmSoc #SPSvirtual202 . Showcasing our exciting new pre chemistry In-Silico assay & post chemistry In-Vitro assay. @ProfH_Maddock @CovUni_SELS @innovateuk
Great to see our industrial PhD student Adam Linekar presenting data from his research at #SPSvirtual2021 @ProfH_Maddock @SafetyPharmSoc @CovUniResearch
The InoCardia team will be attending SPS2021! We have 5 posters (#17, 20, 21, 45, 46), 5 rapid fire presentations, booth 11, and a presentation Thursday 7th October at 12:30pm. Please come along and find out all the new exciting offerings we have. #SPSVirtual2021
InoCardia retweeted
Looking forward to giving a talk today about Cancer Treatment-Related Cardiotoxicity & Approaches to Improve Anti-cancer Medication Development #saferdrugs @InoCardia @InnovateUK @CovUni_SELS
🔊It's finally here!🔊
Today is the first day of #Pharmacology2020! Join us for exclusive scientific sessions, iPosters, networking, BTS content, careers advice and a whole lot more! Joining instructions will hit your inbox by 09:00 GMT. See you soon! buff.ly/3gJI7SW
InoCardia retweeted
Robert Scoffin, CEO, reviews 2020 - from scientific developments, software and services solutions, to the important partnerships we have developed.
bit.ly/2IpmPgU
#ComputationalChemistry #DrugDiscovery @TrackingBoards @ChiroChem @InoCardia @openforcefield @3dneonet
InoCardia retweeted
Well done team! Very proud!
@InoCardia @CovUni_SELS @BPS @innovateuk @SafetyPharmSoc @PaulN_CovUni @TheBHF coventry.ac.uk/research/abou…
First of 2 posters at @SafetyPharmSoc 2020. Development of a Predictive Inotropy In Silico Cardiac Safety Assay for Drug Candidate Screening. Large data set from our WorkLoop assay feeding into the In Silico model.
@ucb_news
@cressetgroup
@innovateuk
#AI is changing medicines development for the better. Find out how UCB is partnering with others to use #machinelearning to develop safer medicines for patients.
InoCardia retweeted
A @covcampus spin-out has been selected to test the safety of new drugs being developed to combat #COVID19. #InoCardia has been awarded £50,000 to ensure the new anti-virals will not cause damage to the heart. Read more: coventry.ac.uk/news/2020/ino… #CovResearch @CovUni_SELS
InoCardia are pleased to announce a collaboration with Cresset Discovery Services to develop improved computational methods for cardiac safety assessment. This collaboration also includes Coventry University, UCB and is supported by EIT Digital.
#CardiacSafety #DrugDevelopment
Cresset Discovery Services and InoCardia announce a one year collaboration to develop improved computational methods for cardiac safety assessment
bit.ly/37pfhTz
#DrugDiscovery #CompChem #CardiacSafety #RandD #InSilicoPredictions
